Two well-characterized papillary thyroid cancer cell lines, TPC-1 and BCPAP, harboring the RET/PTC and BRAFV600E oncogenes, respectively, were used to investigate the role of the integrin α3β1 in adhesion to ECM [29]. The gene discussed is RET; the disease is thyroid gland papillary carcinoma.